BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 32141280)

  • 1. [Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19].
    Chen C; Chen C; Yan JT; Zhou N; Zhao JP; Wang DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):567-571. PubMed ID: 32141280
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).
    Guo T; Fan Y; Chen M; Wu X; Zhang L; He T; Wang H; Wan J; Wang X; Lu Z
    JAMA Cardiol; 2020 Jul; 5(7):811-818. PubMed ID: 32219356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
    Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
    J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19.
    He X; Wang L; Wang H; Xie Y; Yu Y; Sun J; Yan J; Du Y; Shen Y; Zeng H
    Sci Rep; 2020 Nov; 10(1):20452. PubMed ID: 33235220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease.
    Cao J; Zheng Y; Luo Z; Mei Z; Yao Y; Liu Z; Liang C; Yang H; Song Y; Yu K; Gao Y; Zhu C; Huang Z; Qian J; Ge J
    Theranostics; 2020; 10(21):9663-9673. PubMed ID: 32863952
    [No Abstract]   [Full Text] [Related]  

  • 6. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19.
    Stefanini GG; Chiarito M; Ferrante G; Cannata F; Azzolini E; Viggiani G; De Marco A; Briani M; Bocciolone M; Bragato R; Corrada E; Gasparini GL; Marconi M; Monti L; Pagnotta PA; Panico C; Pini D; Regazzoli D; My I; Kallikourdis M; Ciccarelli M; Badalamenti S; Aghemo A; Reimers B; Condorelli G;
    Heart; 2020 Oct; 106(19):1512-1518. PubMed ID: 32817312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risks factors for death among COVID-19 patients combined with hypertension, coronary heart disease or diabetes].
    Yang H; Yang LC; Zhang RT; Ling YP; Ge QG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 52(3):420-424. PubMed ID: 32541972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial injury in severe and critical coronavirus disease 2019 patients.
    Guo H; Shen Y; Wu N; Sun X
    J Card Surg; 2021 Jan; 36(1):82-88. PubMed ID: 33135188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current role of cardiac biomarkers in extra-cardiac diseases in children.
    Rodriguez-Gonzalez M; A Perez-Reviriego A; Castellano-Martinez A
    Biomark Med; 2020 Sep; 14(13):1183-1187. PubMed ID: 33021387
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China.
    Han H; Xie L; Liu R; Yang J; Liu F; Wu K; Chen L; Hou W; Feng Y; Zhu C
    J Med Virol; 2020 Jul; 92(7):819-823. PubMed ID: 32232979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected Features of Cardiac Pathology in COVID-19 Infection.
    Fox SE; Li G; Akmatbekov A; Harbert JL; Lameira FS; Brown JQ; Vander Heide RS
    Circulation; 2020 Sep; 142(11):1123-1125. PubMed ID: 32689809
    [No Abstract]   [Full Text] [Related]  

  • 12. The diagnostic and prognostic role of myocardial injury biomarkers in hospitalized patients with COVID-19.
    Deng P; Ke Z; Ying B; Qiao B; Yuan L
    Clin Chim Acta; 2020 Nov; 510():186-190. PubMed ID: 32681933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.
    Hamaya R; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Kanno Y; Murai T; Lee T; Kakuta T
    Heart Vessels; 2019 Mar; 34(3):410-418. PubMed ID: 30229410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19.
    Qin JJ; Cheng X; Zhou F; Lei F; Akolkar G; Cai J; Zhang XJ; Blet A; Xie J; Zhang P; Liu YM; Huang Z; Zhao LP; Lin L; Xia M; Chen MM; Song X; Bai L; Chen Z; Zhang X; Xiang D; Chen J; Xu Q; Ma X; Touyz RM; Gao C; Wang H; Liu L; Mao W; Luo P; Yan Y; Ye P; Chen M; Chen G; Zhu L; She ZG; Huang X; Yuan Y; Zhang BH; Wang Y; Liu PP; Li H
    Hypertension; 2020 Oct; 76(4):1104-1112. PubMed ID: 32673499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of severe or critical ill patients with COVID-19].
    Xie W; Zhu S; Liu Y; Bai Y; Fu W; Chen H; Chen Z; Zhang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1112-1118. PubMed ID: 32895171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Injury Patterns and Inpatient Outcomes Among Patients Admitted With COVID-19.
    Raad M; Dabbagh M; Gorgis S; Yan J; Chehab O; Dagher C; Jamoor K; Hussein IH; Cook B; Van Harn M; Singh G; McCord J; Parikh S
    Am J Cardiol; 2020 Oct; 133():154-161. PubMed ID: 32829913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics and death risk factors of severe COVID-19].
    Qin W; Hu BZ; Zhang Z; Chen S; Li FJ; Zhu ZY; Wang XJ; Liu M; Li CH
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Aug; 43(8):648-653. PubMed ID: 32727175
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of Cardiovascular Disease on Clinical Characteristics and Outcomes of Coronavirus Disease 2019 (COVID-19).
    Xie Y; You Q; Wu C; Cao S; Qu G; Yan X; Han X; Wang C; Zhang H
    Circ J; 2020 Jul; 84(8):1277-1283. PubMed ID: 32536672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac damage in patients with the severe type of coronavirus disease 2019 (COVID-19).
    Li J; Zhang Y; Wang F; Liu B; Li H; Tang G; Chang Z; Liu A; Fu C; Lv Y; Gao J; Li J
    BMC Cardiovasc Disord; 2020 Nov; 20(1):479. PubMed ID: 33167876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study.
    Cheng H; Fan WZ; Wang SC; Liu ZH; Zang HL; Wang LZ; Liu HJ; Shen XH; Liang SQ
    J Crit Care; 2015 Jun; 30(3):654.e9-14. PubMed ID: 25575850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.